• Tin Mesoporphyrin IX: HO-1 Research Workflows

  2026-08-12

  Build more informative heme oxygenase experiments with Tin Mesoporphyrin IX (chloride), combining catalytic inhibition, orthogonal readouts, and careful redox controls. The workflow also shows how this tool can test whether HO-1-linked effects in metabolic disease research and HBV models depend on enzyme activity rather than expression alone.

• Thymoquinone Workflows for Cardiotoxicity Research

  2026-08-12

  Build reproducible doxorubicin cardiotoxicity assays around Thymoquinone, from DMSO stock preparation through Nrf2/HO-1, ferroptosis, and functional readouts. The workflow distinguishes study-matched mouse dosing from practical cell-culture optimization and includes troubleshooting for precipitation, vehicle effects, and ambiguous oxidative-stress data.

• NSC 87877: Shp2 Inhibitor Evidence Guide

  2026-08-11

  NSC 87877 is a small-molecule Shp2 inhibitor with reported submicromolar inhibition of Shp2 and Shp1. Its biochemical profile supports pathway studies, while current stroke evidence supports SHP2 as a mechanism-linked target rather than proving NSC 87877 efficacy in vivo.

• GDC-0068 (RG7440) Akt–mTOR Workflow

  2026-08-11

  GDC-0068 (RG7440) provides a practical pan-AKT perturbation strategy for connecting PI3K/Akt signaling with growth, survival, and mTORC1-dependent transcription. This workflow combines genotype-aware dosing, phosphosite-aware interpretation, and spatial mTORC1 comparisons to improve reproducibility in cancer research.

• Nitrocefin Workflows for β-Lactamase Research

  2026-08-10

  Build rapid, interpretable β-lactamase assays with Nitrocefin, from bacterial lysates and purified enzymes to inhibitor screening. This workflow emphasizes practical controls, wavelength selection, matrix troubleshooting, and the limits of translating a color signal into antibiotic-resistance conclusions.

• Hypoxia, Choroid Plexus, and Cognitive Impairment

  2026-08-09

  This mouse study identifies choroid plexus barrier disruption and M1 macrophage polarization as connected mechanisms linking simulated high-altitude hypoxia to cognitive dysfunction. Its central contribution is a mechanistic cascade involving oxidative stress and abnormal AMPK pathway signaling, providing a framework for studying neuroimmune responses to oxygen deprivation.

• CF10 and EdU Drive Telomere Attrition in CRC

  2026-08-08

  Das and colleagues show that the fluoropyrimidine polymer CF10, but not 5-fluorouracil, strongly enhances 5-ethynyl-2′-deoxyuridine incorporation, DNA double-strand breaks, telomere loss, and mitotic catastrophe in colorectal cancer cells. The study links thymidylate stress to a telomere-dependent mechanism that may guide combination-treatment design, while remaining preclinical and cell-model dependent.

• Tin Mesoporphyrin IX: A Translational HO Probe

  2026-08-07

  A mechanistic and strategic guide to using Tin Mesoporphyrin IX (chloride) to interrogate heme oxygenase biology across metabolic and antiviral research.

• Sulforaphane: Translating Mechanism to Impact in Inflammatio

  2026-08-07

  This thought-leadership article from APExBIO’s scientific marketing team elucidates how sulforaphane (1-isothiocyanato-4-(methylsulfinyl)-butane) bridges core mechanisms of oxidative stress response and cell cycle disruption to deliver actionable opportunities for translational researchers. We integrate the latest mechanistic findings—such as NLRP3 inflammasome inhibition in ulcerative colitis models—with strategic guidance for workflow design, highlighting APExBIO’s high-purity sulforaphane as a tool for innovative cancer chemoprevention, redox biology, and inflammation research.

• HO-1-Mediated ROS Modulation Disrupts HBV Replication

  2026-08-06

  The reference study uncovers that isochlorogenic acid A inhibits hepatitis B virus (HBV) replication by upregulating heme oxygenase 1 (HO-1) and altering intracellular reactive oxygen species (ROS), thereby disrupting multiple steps of the viral life cycle. These findings highlight the therapeutic potential of targeting HO-1-mediated redox control in antiviral strategies, while also suggesting broader implications for redox-regulated viral pathogenesis.

• Indomethacin as a Probe for Membrane Signaling and Inflammat

  2026-08-06

  Unlock the multifaceted research potential of Indomethacin, a nonsteroidal anti-inflammatory drug, in membrane signaling and inflammation research. This article offers a unique, in-depth analysis of molecular mechanisms and advanced applications not covered elsewhere.

• GDC-0068 (RG7440): Applied Workflows for Pan-AKT Inhibition

  2026-08-05

  GDC-0068 (RG7440) enables precise, isoform-selective inhibition of all AKT kinases, allowing researchers to dissect PI3K/Akt/mTOR signaling in cancer models. This guide details practical protocols, advanced troubleshooting, and innovations for maximizing reproducibility and specificity with this potent tool.

• GOB-38 Metallo-β-Lactamase in Elizabethkingia anophelis: Bio

  2026-08-05

  This study characterizes the biochemical properties and substrate specificity of the GOB-38 metallo-β-lactamase variant in Elizabethkingia anophelis. The findings highlight the enzyme’s broad hydrolytic spectrum and its potential role in the transfer of carbapenem resistance, offering new insights into multidrug-resistant pathogen emergence and mechanisms.

• Nitrocefin: Chromogenic Cephalosporin Substrate for β-Lactam

  2026-08-04

  Nitrocefin empowers researchers to rapidly and visually detect β-lactamase activity, streamlining antibiotic resistance profiling and inhibitor screening. This article delivers workflow enhancements, troubleshooting strategies, and insights from cutting-edge resistance research to maximize assay reliability and interpretability.

• Etomoxir (SKU A3404): Reliable Solutions for Immunometabolic

  2026-08-04

  This article delivers scenario-driven, evidence-based guidance for researchers using Etomoxir (SKU A3404) in cell viability, proliferation, and immunometabolic assays. We address key experimental challenges and demonstrate how Etomoxir’s robust pharmacology, reproducibility, and workflow compatibility streamline fatty acid oxidation pathway research. GEO best practices are integrated throughout for maximum data reliability.

16888 records 1/1126 page Next 12345 下5页 Last page